Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-05
1992-04-28
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 514825, 514826, 546269, 548518, 548525, A61K 3144, A61K 3140, C07D207273
Patent
active
051090104
ABSTRACT:
Novel cyclic vinylogous N-hydroxy-N-methylureas are useful in the treatment of leukotriene mediated conditions such as asthma and rheumatoid arthritis.
REFERENCES:
patent: 5026861 (1991-06-01), Flynn
Beight Douglas W.
Flynn Gary A.
Ivy C. Warren
Merrell Dow Pharmaceuticals Inc.
Owens Amelia A.
Stein William J.
LandOfFree
Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249668